WVE Q4 2023 Earnings — Wave Life Sciences Ltd. Revenue & Financial Results | Market Cap Arena

WVEWave Life Sciences Ltd.

$3B

Q4 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$29M+2245.1% YoY

Gross Profit

$27M92.5% margin

Operating Income

-$19M-64.3% margin

Net Income

-$16M-55.9% margin

EPS (Diluted)

$-0.15

QoQ Revenue Growth

-41.0%

Cash Flow

Operating Cash Flow

-$33M

Free Cash Flow

-$34M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$275M

Total Liabilities

$235M

Stockholders' Equity

$40M

Cash & Equivalents

$200M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$29M	$1M	+2245.1%
Gross Profit	$27M	-$30M	+190.1%
Operating Income	-$19M	-$44M	+57.1%
Net Income	-$16M	-$44M	+62.8%